Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease

Background: Reduction of serum LDL-cholesterol by statins was shown to improve clinical outcomes in patients with coronary heart disease (CHD). Although intensive statin therapy significantly reduced cardiovascular risks, atherosclerotic cardiovascular events have not been completely prevented. Ther...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Atheroscler Thromb
Autori principali: Yamashita, Shizuya, Masuda, Daisaku, Ohama, Tohru, Arai, Hidenori, Bujo, Hideaki, Kagimura, Tatsuo, Kita, Toru, Matsuzaki, Masunori, Saito, Yasushi, Fukushima, Masanori, Matsuzawa, Yuji
Natura: Artigo
Lingua:Inglês
Pubblicazione: Japan Atherosclerosis Society 2016
Soggetti:
Study Profile
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399286/
https://ncbi.nlm.nih.gov/pubmed/26803913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.32813
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi